EW
Companies
Nyse American
Edwards Lifesciences Corporation
Health Care
$74.00
-$0.03 (-0.04%)
Price Chart
Overview
About EW
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
Market Cap
$53.1B
Volume
342.4M
Avg. Volume
354.1M
P/E Ratio
28.29796
Dividend Yield
0.00%
Employees
15.9K
Company Information
Risk & Correlation Analysis
Market Correlation
1.00
Moderate Correlation
Volatility
Medium (0.36)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, EW shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$53.1B
Volume342.4M
P/E Ratio28.30
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 12, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025